Information Provided By: 
Fly News Breaks for September 26, 2016
DBD
Sep 26, 2016 | 06:08 EDT
JPMorgan analyst Paul Coster upgraded Diebold to Overweight saying the 13% pullback over the past month provides an opportunity to buy the shares at an attractive multiple. The current valuation offsets the near-term risks associated with acquisition of Wincor Nixdorf, Coster tells investors in a research note. The analyst keeps a $33 price target for the shares.
News For DBD From the Last 2 Days
